DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...
Over the last 10 months, the Congress government secured agreements for 140 Life Sciences or pharmaceutical projects ...
In August 2024, TG Therapeutics announced that the FDA has cleared an investigational new drug (IND) application submitted by TG Therapeutics for azercabtagene zapreleucel (azer-cel), an ...
THE CHOSUNILBO on MSN19h
Korean pharma accelerates FDA efforts, betting on regulatory shiftsYuhan Corp. posted record-breaking third-quarter results, with revenue reaching 598.8 billion won and operating profit ...
Appointed Douglas Williams, Ph.D. as Chair of the Board of DirectorsFDA Clearance of Investigational New Drug Application (IND) for systemic ...
Department of Physiology, Harold Hamm Diabetes Center, The University of Oklahoma Health Science Center, Oklahoma City, United States ...
Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...
We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.
But one of the most powerful aspiring entrants, Novo Nordisk, may not be as intimidating for the biotech as it once was. Novo's molecule semaglutide (commonly known by the trade names Ozempic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback